How a False Alarm Affects Future Cancer Screenings

MONDAY, April 23, 2018 -- A cancer scare could increase the chances that you'll be diligent about recommended screenings in the future, a new study finds. People who got a false-positive result on a breast or prostate cancer screening test were more...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

CONCLUSIONS: Afro-Caribbean populations in French West Indies share the same major clinical and pathological risk factors of BCR after RP identified in other ethnic groups. Perioperative blood loss appears to be an additional and independent predictive factor of BCR. LEVEL OF PROOF: 4. PMID: 29789237 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
CONCLUSION: A reduction of LUTS is observed in patients with locally advanced or metastatic prostate cancer treated with triptorelin in routine practice. This is in agreement with similar observational studies of triptorelin conducted in other countries. LEVEL OF PROOF: 4. PMID: 29789236 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
CONCLUSION: Mp-MRI is a useful exam for selecting patients eligible for AS even if the situation remains unclear after prostate biopsies including targeted biopsies. Upon confirmation by further studies, mp-MRI should be considered as an independent criterion before entering an AS program. LEVEL OF EVIDENCE: 4. PMID: 29789235 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
CONCLUSIONS: In this study obese men do not appear to have a significant increase in risk of PSMs at RP compared to lean and overweight men when operated by a minimally invasive approach. The magnified vision and increased access to the pelvis allowed by a laparoscopic and robotic-assisted approach may be accountable for our findings. Larger studies are needed to validate our results. LEVEL OF PROOF: 4. PMID: 29789234 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
Is active surveillance for low-risk prostate cancer preferred in men who strongly want to preserve sexual function?Journal of the National Cancer Institute
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Publication date: Available online 24 May 2018 Source:European Urology Author(s): Giovanni Lughezzani, Nicolo’ Maria Buffi, Massimo Lazzeri
Source: European Urology - Category: Urology & Nephrology Source Type: research
Publication date: Available online 24 May 2018 Source:European Urology Author(s): Vincenza Conteduca, Giorgia Gurioli, Ugo De Giorgi
Source: European Urology - Category: Urology & Nephrology Source Type: research
Erleada (apalutamide) is the first treatment approved for nonmetastatic, castration-resistant prostate cancer.If patients prescribed apalutamide are also taking other drugs metabolized by the same cytochrome P-450 isoenzyme systems, the circulating levels of apalutamide may be altered.
Source: AJN - Category: Nursing Tags: Drug Watch Source Type: research
Saw palmetto is an herbal remedy with many potential uses in healthcare. One such use is the treatment of benign prostate hyperplasia (BPH). Although a popular remedy, research into the herb ’s efficacy is still ongoing and the results to date are inconclusive. Here, we look at the other treatments also available.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
Findings for men with intermediate - and high - risk prostate cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pathology, Urology, Journal, Source Type: news
More News: Cancer | Cancer & Oncology | General Medicine | Prostate Cancer | Study